CoChat

The impact of pyrvinium pamoate on colon cancer cell viability

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Purpose The in vitro and in vivo effects of pyrvinium pamoate (PP), a newly identified WNT signaling inhibitor, were evaluated against colon cancer cell lines and primary colon cancer samples. Experimental design Antiproliferative activity of PP and its effects on protein and RNA levels of WNT targets were evaluated on adenomatous polyposis coli (APC (mut)) and β-catenin(mut) cell lines, one WNT(wt) colon cancer cell line, as well as six primary colon cancer samples with mutant APC in vitro. In addition, the effect of PP on the growth of liver metastasis was examined. Results PP blocked colon cancer cell growth in vitro in a dose-dependent manner with great differences in the inhibitory concentration (IC(50)), ranging from 0.6 × 10(-6) to 65 × 10(-6) mol/L for colon cancer cells with mutations in WNT signaling. In addition, PP demonstrated a cytotoxic effect on primary colon cancer samples. A combined cytotoxic effect of PP with 5-fluorouracil (5-FU) was observed for two cell lines. PP decreased messenger RNA (mRNA) and protein levels of known WNT target genes as c-MYC and thereby led to the induction of p21. PP inhibited the migration of HCT116 colon cancer cells in vitro and decreased tumor growth in vivo after intraportal injection of HCT116 cells in nude mice. Conclusions PP displays promising anticancer activity against a broad panel of human colon cancer cell lines, as well as primary colon cancer samples. However, our findings do not demonstrate a predominant cytotoxic…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00384-014-1975-y

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Cited by

See all 37

Metadata

Authors
Wiegering, A., Uthe, F.-W., Hüttenrauch, M., Mühling, B., Linnebacher, M., Krummenast, F., Germer, C.-T., Thalheimer, A., & Otto, C.
Affiliations
  • Universitätsklinikum Würzburg (DE)
  • University of Würzburg (DE)
  • University of Rostock (DE)
Corresponding author
  • Wiegering, Armin
  • Otto, Christoph
Venue
International Journal of Colorectal Disease
Published
2014-07-26
Volume
29
Issue
10
Pages
1189-1198
ISSN
  • 0179-1958 (ISSN-L)
  • 1432-1262
OpenAlex
W2064172924
Cited by
37
References
29
Citations by year
2026: 1 · 2025: 2 · 2024: 8 · 2023: 1 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 1
FWCI
1.36
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • International Journal of Colorectal Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
pyrvinium pamoate, colon cancer, Wnt signaling inhibition, APC mutation, CTNNB1 mutation, c-Myc, p21, cell migration, liver metastasis, antiproliferative activity, cytotoxicity
MeSH terms
Animals, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Cell Movement, Cell Survival, Colonic Neoplasms, Fluorouracil, Humans, Liver Neoplasms, Pyrvinium Compounds, Genes, APC, Inhibitory Concentration 50, Cell Line, Tumor, beta Catenin, Mice, Wnt Signaling Pathway, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of pyrvinium pamoate on colon cancer cell viability. https://app.cochat.ai/papers/10.1007/s00384-014-1975-y
The paper
Wiegering, A., Uthe, F.-W., Hüttenrauch, M., Mühling, B., Linnebacher, M., Krummenast, F., Germer, C.-T., Thalheimer, A., & Otto, C. (2014). The impact of pyrvinium pamoate on colon cancer cell viability. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-014-1975-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.